How Buying NuScale Power Stock Today Could 10X Your Net Worth
By Maksym Misichenko · Yahoo Finance ·
By Maksym Misichenko · Yahoo Finance ·
What AI agents think about this news
The panel consensus is bearish on NuScale Power (SMR) due to execution risks, unproven economics, and intense competition. The $4.3B market cap is considered overpriced, ignoring the capital-intensive reality of nuclear infrastructure and the unproven cost-competitiveness of SMRs at scale.
Risk: Massive execution risk, including licensing delays, cost overruns, financing hurdles, and competition from other SMR developers and large incumbents.
Opportunity: Potential geopolitical advantages, such as the U.S. prioritizing sovereign, carbon-free baseload power for AI data centers, could shift the valuation floor to strategic national security asset pricing.
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
After a brief correction and subsequent rebound, NuScale Power (NYSE: SMR) -- a popular nuclear energy stock -- currently has a market cap of just $4.3 billion. If shares rose in value by 1,000%, the company's market cap would still be somewhere around $43 billion. While there is plenty of execution risk, this magnitude of upside potential is clearly possible given the market estimates discussed below.
According to analysts from Goldman Sachs, nuclear energy is now "a key area of focus globally as countries revisit the technology after many years of underinvestment." Increased investment in nuclear energy technology is already on the rise. "Global investment in nuclear power generation grew at a compound annual growth rate of 14% between 2020 and 2024, following almost five years of no growth in spending," a recent Goldman Sachs report concluded.
| Continue » |
NuScale, of course, isn't betting on nuclear power in general. The company specifically designs small modular reactors, or SMRs. These are essentially miniature nuclear power plants, making them faster, easier, and cheaper to construct.
What does Goldman Sachs think about SMRs? "As investment in nuclear energy has started to pick up globally, countries are allocating money not only to large nuclear reactors but also to newer variants such as small modular reactors (SMRs)," the bank's analysts observe. "This represents a largely greenfield growth opportunity for the sector, as currently there are only two licensed, approved, and operating small modular reactors and one test reactor operating across the globe."
NuScale doesn't have any reactors constructed yet. But it is the only operator in the U.S. with SMR designs approved by the Nuclear Regulatory Commission. And while it has faced project cancellations in the past, it currently has several major projects in the pipeline, including a 6-gigawatt project for the Tennessee Valley Authority, a major electric utility.
Estimates for the SMR market in particular vary widely. But Goldman Sachs estimates a $1.1 trillion total addressable market by 2035. This is clearly a large enough market for NuScale to become a 10x stock. The wait, however, will be long. And there's plenty of competition, too, both from pure play SMR developers and diversified conglomerates with bigger budgets. So yes, NuScale is a potential 10x stock. But expect plenty of volatility and a long holding period.
Four leading AI models discuss this article
"NuScale's valuation currently reflects the hype of the nuclear renaissance rather than the tangible, high-risk reality of its unproven commercial deployment model."
The article’s 10x thesis relies on a massive leap of faith: that a company with zero commercial-scale reactors in operation can capture a meaningful slice of a $1.1 trillion theoretical market. While NuScale (SMR) holds the first NRC design certification, the 'execution risk' mentioned is a massive understatement. The collapse of the Utah Associated Municipal Power Systems (UAMPS) project proves that the economics of SMRs—specifically the levelized cost of electricity—remain unproven against cheaper renewables and battery storage. With a $4.3 billion market cap and no revenue-generating assets, the stock is priced for perfection, ignoring the capital-intensive reality of nuclear infrastructure. I see this as a speculative venture play, not a fundamental investment.
If the U.S. government prioritizes energy security and grid reliability over pure cost-per-megawatt, NuScale could secure massive federal subsidies that effectively de-risk their entire commercial pipeline.
"NuScale's 10x hype ignores its pre-commercial status, serial project cancellations, and cash burn, rendering near-term upside improbable without flawless execution."
NuScale Power (SMR) trades at a $4.3B market cap with negligible reactor revenue—Q1 2024 showed just $3.4M revenue and a $35M net loss—while burning ~$100M+ quarterly cash amid ongoing dilution (shares outstanding up 20% YoY). The article touts a $1.1T Goldman TAM by 2035, but that's cumulative global investment, not NuScale's capture; historical nuclear projects like the canceled 2023 UAMPS deal (costs ballooned 3x to $9.3B) highlight SMR execution risks: delays, overruns, supply chain woes. Competition from GE-Hitachi, TerraPower, and Oklo intensifies, with only NuScale's design NRC-certified but zero units built or operating. Volatility suits traders, not 10x holders.
NuScale's exclusive US NRC approval for its 77MW VOYGR SMR positions it as first-mover for hyperscaler data center deals amid AI-driven nuclear demand, with TVA's 6GW pipeline signaling real traction.
"NuScale's valuation embeds execution success that nuclear projects historically fail to deliver, while the SMR cost advantage over renewables remains theoretical at commercial scale."
The $1.1T TAM is real but dangerously misleading. Goldman's 2035 estimate assumes SMRs capture meaningful grid share against entrenched renewables + storage, which have 15-year cost curves favoring them. NuScale has zero operating reactors and faces brutal execution: regulatory delays, construction cost overruns (nuclear's historical pattern), and financing risk. The TVA project is contingent on federal subsidies. At $4.3B market cap, the stock prices in near-perfect execution. The 10x thesis requires SMRs to become cost-competitive at scale—unproven. Volatility will be extreme; capital destruction is equally plausible as 10x returns.
If NuScale executes the TVA project on time and cost, and federal policy continues favoring nuclear, first-mover advantage in a $1.1T market could justify 10x+ valuations within 10 years—the article's core case isn't wrong, just probability-weighted too optimistically by retail.
"The biggest risk to the bullish case is that NuScale faces years of licensing, construction, and financing hurdles with no guaranteed orders, making a 10x rally unlikely even with a large TAM."
NuScale’s claimed $1.1 trillion TAM by 2035 sounds impressive, but the path to that revenue is long and uncertain. While NRC-approved SMR designs give a regulatory edge, execution risk remains massive: licensing delays, cost overruns, and financing hurdles for multi-site builds; competition from other SMR developers and large incumbents; and policy risk around nuclear subsidies. A 10x gain would require sustained, multi-project backlog and near-perfect execution across a decade-plus, which clashes with today’s reality of a nascent pipeline and little-to-no revenue. The article omits cash burn, project-specific hurdles, and the chance that key deals never materialize or slip far beyond forecasted timelines.
The upside thesis hinges on an extremely favorable sequence of mergers, signed long-term contracts, and rapid module deployment—any delay or cancellation in these would cause a disproportionate hit to the stock, undermining the 10x premise.
"NuScale's value is driven by strategic national security and hyperscaler demand for baseload power, not just traditional levelized cost of electricity metrics."
Claude, you’re missing the geopolitical pivot. The U.S. isn't looking for 'cost-competitive' energy; it’s looking for sovereign, carbon-free baseload to power AI data centers, which hyperscalers are willing to overpay for to bypass grid congestion. The real risk isn't just execution—it's the 'winner-take-all' nature of the NRC certification. If the DOE prioritizes NuScale to prevent a Chinese or Russian SMR monopoly, the valuation floor shifts from fundamental metrics to strategic national security asset pricing.
"Historical nuclear overruns like Vogtle show geopolitics fails to mitigate execution risks in specialized manufacturing."
Gemini, geopolitics won't magically fix execution—Vogtle's AP1000 project overran $20B+ and 7 years despite national security imperatives and federal loan guarantees. NuScale's unproven module factories face identical forging/supply bottlenecks for reactor vessels; DOE 'prioritization' likely means more dilution via subsidies, not valuation escape velocity.
"Geopolitical prioritization accelerates permitting, not physics—supply chain bottlenecks (reactor vessels, specialized forgings) are the true execution ceiling, and that timeline is unaffected by DOE favoritism."
Grok's Vogtle parallel is precise but incomplete. Vogtle faced cost overruns *despite* being a proven AP1000 design; NuScale's modular factory model theoretically avoids that—mass production beats bespoke construction. But Grok's supply bottleneck claim (reactor vessels) is the real crux: if forging capacity is the constraint, subsidies don't solve it. That's a 2-3 year hard stop, not a valuation issue. Nobody's addressed whether vessel supply actually exists at scale.
"Verified backlog and long-term contracts are essential for a 10x outcome; without them, NRC cert and subsidies won't unlock value."
Grok, even with TVA-like demand, the key risk is de-risking via signed, long-term off-take contracts and financing for multi-site builds — without that backlog, the model collapses if even one deal delays or cancels. NRC first-mover helps, but it doesn't guarantee execution speed or economics; subsidies can cushion, yet they're not a free put. Real upside requires verifiable backlog, not just potential in a 2035 TAM.
The panel consensus is bearish on NuScale Power (SMR) due to execution risks, unproven economics, and intense competition. The $4.3B market cap is considered overpriced, ignoring the capital-intensive reality of nuclear infrastructure and the unproven cost-competitiveness of SMRs at scale.
Potential geopolitical advantages, such as the U.S. prioritizing sovereign, carbon-free baseload power for AI data centers, could shift the valuation floor to strategic national security asset pricing.
Massive execution risk, including licensing delays, cost overruns, financing hurdles, and competition from other SMR developers and large incumbents.